SCIENTIFIC GAMES CORP (SGMS) Fundamental Analysis & Valuation

NASDAQ:SGMS • US80874P1093

Current stock price

58.07
+1.32 (+2.33%)
At close:
58.07
0 (0%)
After Hours:

This SGMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SGMS Profitability Analysis

1.1 Basic Checks

  • SGMS had positive earnings in the past year.
SGMS Yearly Net Income VS EBIT VS OCF VS FCFSGMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 200M -200M 400M -400M 600M

1.2 Ratios

Industry RankSector Rank
ROA 4.52%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGMS Yearly ROA, ROE, ROICSGMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 10 -10 20

1.3 Margins

Industry RankSector Rank
OM 13.15%
PM (TTM) 12.35%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGMS Yearly Profit, Operating, Gross MarginsSGMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. SGMS Health Analysis

2.1 Basic Checks

  • SGMS has more shares outstanding than it did 1 year ago.
  • SGMS has a better debt/assets ratio than last year.
SGMS Yearly Shares OutstandingSGMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
SGMS Yearly Total Debt VS Total AssetsSGMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 0.37, we must say that SGMS is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of -3.83 indicates that SGMS is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -3.83
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACCN/A
WACCN/A
SGMS Yearly LT Debt VS Equity VS FCFSGMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 2B -2B 4B 6B 8B

2.3 Liquidity

  • SGMS has a Current Ratio of 1.78. This is a normal value and indicates that SGMS is financially healthy and should not expect problems in meeting its short term obligations.
  • SGMS has a Quick Ratio of 1.68. This is a normal value and indicates that SGMS is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.68
SGMS Yearly Current Assets VS Current LiabilitesSGMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SGMS Growth Analysis

3.1 Past

  • SGMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 166.95%, which is quite impressive.
  • The Revenue has been growing slightly by 5.80% in the past year.
  • Measured over the past years, SGMS shows a decrease in Revenue. The Revenue has been decreasing by -5.67% on average per year.
EPS 1Y (TTM)166.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)5.8%
Revenue growth 3Y-13.82%
Revenue growth 5Y-5.67%
Sales Q2Q%-23.75%

3.2 Future

  • Based on estimates for the next years, SGMS will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.52% on average per year.
  • Based on estimates for the next years, SGMS will show a small growth in Revenue. The Revenue will grow by 0.78% on average per year.
EPS Next Y-61%
EPS Next 2Y-8.45%
EPS Next 3Y-7.2%
EPS Next 5Y13.52%
Revenue Next Year-10.08%
Revenue Next 2Y-0.9%
Revenue Next 3Y-0.83%
Revenue Next 5Y0.78%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SGMS Yearly Revenue VS EstimatesSGMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
SGMS Yearly EPS VS EstimatesSGMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5 -10

More info and screens

Find the best growth stocksShow best growing peers

1

4. SGMS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.49, SGMS is valued on the expensive side.
  • SGMS is valuated rather cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 47.42, which means the current valuation is very expensive for SGMS.
  • SGMS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.68.
Industry RankSector Rank
PE 18.49
Fwd PE 47.42
SGMS Price Earnings VS Forward Price EarningsSGMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.68
SGMS Per share dataSGMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

  • SGMS's earnings are expected to decrease with -7.20% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.45%
EPS Next 3Y-7.2%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SGMS Dividend Analysis

5.1 Amount

  • SGMS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SGMS Fundamentals: All Metrics, Ratios and Statistics

SCIENTIFIC GAMES CORP

NASDAQ:SGMS (4/28/2022, 8:26:43 PM)

After market: 58.07 0 (0%)

58.07

+1.32 (+2.33%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-01
Earnings (Next)05-10
Inst Owners64.71%
Inst Owner Change-64.93%
Ins Owners2.74%
Ins Owner Change0%
Market Cap5.63B
Revenue(TTM)2.88B
Net Income(TTM)356.00M
Analysts76.92
Price Target77.65 (33.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.49
Fwd PE 47.42
P/S 1.95
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 17.68
EPS(TTM)3.14
EY5.41%
EPS(NY)1.22
Fwd EY2.11%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS29.71
BVpS-23.26
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.52%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 13.15%
PM (TTM) 12.35%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity -3.83
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.68
Altman-Z 0.37
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)166.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y-61%
EPS Next 2Y-8.45%
EPS Next 3Y-7.2%
EPS Next 5Y13.52%
Revenue 1Y (TTM)5.8%
Revenue growth 3Y-13.82%
Revenue growth 5Y-5.67%
Sales Q2Q%-23.75%
Revenue Next Year-10.08%
Revenue Next 2Y-0.9%
Revenue Next 3Y-0.83%
Revenue Next 5Y0.78%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

SCIENTIFIC GAMES CORP / SGMS Fundamental Analysis FAQ

What is the fundamental rating for SGMS stock?

ChartMill assigns a fundamental rating of 5 / 10 to SGMS.


What is the valuation status for SGMS stock?

ChartMill assigns a valuation rating of 4 / 10 to SCIENTIFIC GAMES CORP (SGMS). This can be considered as Fairly Valued.


Can you provide the profitability details for SCIENTIFIC GAMES CORP?

SCIENTIFIC GAMES CORP (SGMS) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for SGMS stock?

The Price/Earnings (PE) ratio for SCIENTIFIC GAMES CORP (SGMS) is 18.49 and the Price/Book (PB) ratio is -2.5.


Can you provide the expected EPS growth for SGMS stock?

The Earnings per Share (EPS) of SCIENTIFIC GAMES CORP (SGMS) is expected to decline by -61% in the next year.